(Health-NewsWire.Net, July 06, 2017 ) Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI) . TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with TAVR is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.
For more information about this report: http://www.reportsweb.com/global-transcatheter-aortic-valve-replacement-tavr-market-industry-analysis-and-outlook-2017-2021
The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.
The report "Global TAVR Market: Industry Analysis & Outlook (2017-2021) " analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001672817/sample
Table of Contents 1. Introduction 2. Global Market Analysis 3. Regional Market Analysis 4. Market Dynamics 5. Competition 6. Company Profiles 6.1 Edwards Lifesciences 6.1.1 Business Overview 6.1.2 Financial Overview 6.1.3 Business Strategies
6.2 Boston Scientific 6.2.1 Business Overview 6.2.2 Financial Overview 6.2.3 Business Strategies
6.3 Medtronic Plc. 6.3.1 Business Overview 6.3.2 Financial Overview 6.3.3 Business Strategies
6.4 St. Jude Medical, Inc. 6.4.1 Business Overview 6.4.2 Financial Overview 6.4.3 Business Strategies Inquire for Report at http://www.reportsweb.com/inquiry&RW0001672817/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|